Tag: neurodegenerative diseases

CIRC Announces 2023 Annual Results

Blockchain April 17, 2024

HONG KONG, Apr 17, 2024 - (ACN Newswire) - China Isotope & Radiation Corporation (“CIRC” or the “Company” , together with its subsidiaries, the “Group”;...

This Gene Increases the Risk of Alzheimer’s. Scientists Finally Know Why

AI March 15, 2024

ORI Capital Raises $260 Million for Second Life Sciences Fund

Fintech February 22, 2024

This Week’s Awesome Tech Stories From Around the Web (Through February 17)

AI February 17, 2024

Cardiac PET scans could predict onset of neurodegenerative disease in at-risk individuals – Physics World

QuantumJanuary 3, 2024

Researchers have been trying to answer questions about Parkinson’s disease and Lewy body dementia – including where these neurodegenerative diseases start...

A New Brain-Like Supercomputer Aims to Match the Scale of the Human Brain

AIDecember 20, 2023

A supercomputer scheduled to go online in April 2024 will rival the estimated rate of operations in the human brain, according to researchers in...

After Weight Loss, Ozempic Is Set to Conquer a Universe of Brain Disorders

AIDecember 19, 2023

One inescapable word dominated biomedicine this year: Ozempic.Physicians were amazed at the drug’s efficacy in treating diabetes, for which it is FDA approved, and...

Quantum news Briefs: December 11, 2023: Riverlane partners with Infleqtion and Nüvü Camēras; Oxford Quantum Circuits & Classiq Partner to Advance Seamless Quantum Computing;...

QuantumDecember 11, 2023

By Kenna Hughes-Castleberry posted 11 Dec 2023 Quantum News Briefs: December 11, 2023: Riverlane partners with Infleqtion and Nüvü...

Optics and instrumentation firms share in the 2023 Institute of Physics business awards – Physics World

QuantumNovember 27, 2023

James McKenzie celebrates firms in photonics and instrumentation that have won business awards from the Institute of Physics in 2023 ...

Towards a cure for ALS: magnetic stimulation restores impaired motoneurons – Physics World

QuantumJuly 5, 2023

Amyotrophic lateral sclerosis (ALS) is a severe incurable disorder in which motoneurons – nerve cells in the brain and spinal cord...

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease

BlockchainJune 7, 2023

Houston, TX, June 8, 2023 - (ACN Newswire) - Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing multiple therapeutic programs intended to...

Mouse brain imaging reaches record-breaking resolution

QuantumApril 25, 2023

A research team headed up at Duke Center for In Vivo Microscopy has created the...

Piezoelectric nanoparticles provide deep brain stimulation without invasive surgery

QuantumJanuary 4, 2023

Deep brain stimulation (DBS), in which electrodes implanted in the brain deliver electrical impulses to specific targets, is an effective clinical...

Biomind Labs Announces the Completion of the First Sublingual Psychedelic Formulation for Its Drug Candidate BMND08 for Depression and Anxiety in Alzheimer’s Disease

FintechDecember 28, 2022

TORONTO–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next...

Global Pharmaceutical Lipid-based Nanoparticles Research Report 2022: Focus on Pre-clinical and Clinical Advancements – ResearchAndMarkets.com

FintechDecember 22, 2022

DUBLIN–(BUSINESS WIRE)–The “Lipid-based Nanoparticles for the Pharmaceutical Industry: Pre-clinical and Clinical Advancements” report has been added to ResearchAndMarkets.com’s offering. This study offers an in-depth analysis...